KOKirill Orlov

Kirill Orlov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kirill Orlov has a total of 149 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Spontaneous thrombosis of Vein of Galen Arteriovenous Malformation in a toddler

    by Symbattym Bodanova, Боданова Сымбаттым, Vadim Vyacheslavovich Berestov, Берестов Вадим Вячеславович, Kirill Yurevich Orlov, Орлов Кирилл Юрьевич, Gennady Egorovich Chmutin, Чмутин Геннадий Егорович

    BACKGROUND: Galen vein's arteriovenous malformation is a severe congenital pathology often leading to life-threatening conditions such as heart failure and neurological complications. The gold standard of treatment is staged endovascular embolization. However, in rare cases, partial embolization can be followed by spontaneous thrombosis of the residual malformation, which is a favorable outcome. This article presents a clinical case demonstrating this rare phenomenon. CLINICAL CASE DESCRIPTION: A child with a prenatally diagnosed Galen's vein arteriovenous malformation and concomitant heart defects (Ventricular Septal Defect, Patent Ductus Arteriosus, Tricuspid Valve Insufficiency, and secondary Pulmonary Hypertension) underwent two staged endovascular embolizations at the ages of 2.5 and 6 months. Following the second stage, during preparation for the third intervention, magnetic resonance imaging revealed complete thrombosis of the malformation and the Galen's vein, obviating the need for further surgery. The child's condition stabilized, with neurological status and development being age-appropriate. CONCLUSION: This experience demonstrates that a strategy of staged partial embolization can initiate spontaneous Galen's vein arteriovenous malformation thrombosis, leading to complete cure while avoiding the risks of repeated interventions and neurological deficit.

  • Functional Outcomes and Safety of Endovascular Thrombectomy in Pediatric Acute Ischemic Stroke With Cardiac Abnormalities

    by Adam A. Dmytriw, Iman Kiani, Alireza Kooshki, Kartik D. Bhatia, Todd Abruzzo, Lisa Pabst, Stuart Fraser, Melissa Chung, Warren D. Lo, Ahmed Othmann, et al.

    Background and ObjectivesCardiac abnormalities are among the most common and complex risk factors of pediatric acute ischemic stroke (AIS). Although endovascular treatment (EVT) is increasingly use...

  • The first experience of using tenecteplase for the thrombolytic therapy in ischemic stroke in the Russian Federation

    by N.A. Glotova, R.T. Tairova, N.A. Marskaya, M.A. Soldatov, I.L. Gubskiy, K.YU. Orlov, N.A. Shamalov

    Thrombolytic therapy (TLT) is an effective treatment for ischemic stroke (IS). Three fibrinolytic agents are currently registered in the Russian Federation for the treatment of IS, including tenecteplase, which has demonstrated high efficacy and safety in several randomized controlled trials. We present three clinical case reports of patients with IS who, for the first time in the Russian Federation, underwent TLT with the domestically produced biosimilar of tenecteplase, Nektelisa. In all three patients with IS, we observed significant regression of neurological deficits after administration of tenecteplase within the first hour after TLT. The dose was adjusted according to the instructions for use, taking into account the patient’s body weight. In all three cases, the same neuroimaging method was used 24 hours after TLT as upon admission. No increase in the ischemic area was observed in any of the patients after 24 hours. In one case, a minor, clinically asymptomatic subarachnoid hemorrhage was detected, accompanied by rapid and complete recanalization of the occluded artery within the first 30 minutes after drug administration. In all three cases, we did not observe any other extracerebral hemorrhagic events. All patients were admitted with significant impairment of neurological functions and were discharged with mild or no significant impairment.

  • Aneurysms associated with moyamoya angiopathy (clinical cases)

    by M.Sh. Amiralieva, K.S. Ovsyannikov, K.Yu. Orlov, A.I. Somova, A.O. Sosnov, M.B. Dolgushin, O.I. Patsap, I.V. Senko

    Background. The incidence of arterial aneurysms associated with moyamoya angiopathy (AA-MMA) is five times higher than in general population. The risk of AA-MMA rupture can reach 90%. AA-MMA clipping is accompanied by postoperative complications in 25% of cases, and endovascular treatment leads to a forced change of surgical tactic in 26% of cases. In this regard, it is relevant to discuss the features of surgery for AA-MMA and effective treatment algorithm. Objective. To present rare clinical cases of AA-MMA and surgical treatment options. Material and methods. The authors present two patients with ruptured AA-MMA. In the first case, there was a distal aneurysm of the right lenticulostriate artery associated with MMA (Suzuki III). The patient underwent aneurysm embolization followed by combined revascularization three months later. In the second case, aneurysm of ACA-AcomA complex was associated with contralateral MMA. The patient underwent microsurgical clipping of aneurysm and combined revascularization 1.5 months later. Results. These clinical cases demonstrate successful endovascular embolization and microsurgical treatment combined with delayed revascularization for the treatment of AA-MMA. In both cases, aneurysms were successfully removed. Perfusion improved after revascularization in both cases. There were no recurrent strokes throughout 2 years in the first case and 9 years in the second case. Conclusion. AA-MMA is a complex pathology requiring special attention. Standard methods of surgical treatment are often associated with high risk of postoperative complications. Preoperative planning and consideration of pathogenic features of MMA are important.

  • Open Access

    Experimental stage of intrauterine correction of the aneurysm of the vein of Galen

    by N. V. Kosovtsova, K. A. Mavlyutova, K. Yu. Orlov, Ya. Yu. Pospelova, L. V. Kardapoltsev, Я. Ю. Поспелова

    Introduction. Arteriovenous malformation of the vein of Galen (AVM VG) is a rare vascular malformation of the central nervous system, mainly diagnosed in the neonatal or postnatal period. Despite significant advances in the field of neonatal endovascular embolization, the mortality rate and the incidence of severe neurological complications remain high. In this regard, the development of intrauterine surgical technologies opens up prospects for interventions aimed at preventing cardiovascular complications and hypoxic damage to the central nervous system. Objective: Development of a method for intrauterine partial occlusion of arteriovenous malformation of the vein of Galen under ultrasound control in an experiment.Materials and methods. The method of minimally invasive intrauterine embolization of arteriovenous malformation of the vein of Galen refers to the methods of fetal surgery, leads to a decrease in blood shunting and relief of cardiovascular insufficiency. The model of malformation was the left atrium of a sheep fetus. The use of this technique was approved at a meeting of the Ethics Committee of the Ural Research Institute of Occupational Medicine of the Ministry of Health of the Russian Federation on September 12, 2021.Study results. During two experimental interventions on the model of arteriovenous malformation of the vein of Galen, modeled on sheep fetuses, partial intrauterine embolization was successfully performed using microspirals and adhesive compositions. It was found that this technique provides a significant decrease in the blood flow velocity in the chambers of the heart (by 3-4 times), without intraoperative disturbances in the cardiac activity of the fetuses. The use of an adhesive composition prevented the migration of spirals. All fetuses remained alive at the end of the experiments.Conclusion. The proposed technique of partial intrauterine embolization of arteriovenous malformation of the vein of Galen in the experiment showed potential effectiveness in reducing blood flow through the aneurysmally altered vessel. The obtained data confirm the possibility of safe administration of embolic material under ultrasound control, which allows us to consider this approach as a promising stage of preparation for intrauterine treatment of this pathology in high-risk fetuses. Further studies are needed to clarify the criteria for selecting patients and assess the clinical effectiveness of the proposed method.

  • Open Access

    E-208 Flow diverters in treatment of cerebral aneurysms

    by K Orlov, N Strelnikov, V Berestov, A Somova, A Brusyanskaya

    Background Endovascular approach is one of the ways to successfully treat cerebral aneurysms. Currently, there are various techniques and devices to increase the radicality of endovascular treatment. Despite the variety of available techniques, in recent years, flow diverts (FDs) have been increasingly preferred as a method for treating cerebral aneurysms. Materials and Methods From January 2011 to March 2023 at E.Meshalkin National Medical Research Center, Novosibirsk, and Federal Center of Brain Research and Neurotechnologies, Moscow, 3803 endovascular operations to treat cerebral aneurysms were performed. 1009 (26.4%) FDs were implanted, and in the rest of the cases, the patients were treated using other embolization techniques. A retrospective analysis of the results obtained with FDs was carried out. Results The technical success was 96.8%. The frequency of at which FDs were preferred to other techniques to treat cerebral aneurysms for 2011-2015 was 16.7% (n=164), and 28.1% (n=489) for 2016-2020. In 2021, FDs were implanted in 29.6% (n=149) of cases. From 2022 to March 2022, this technique was used in 36.4% (n=227) of the operations performed. According to the control studies (at median 9 months), total occlusion in the entire series has been achieved in 78.1% of cases (n=788), while some patients (n=164) are still waiting for their controls to be performed. For all FD interventions, a severe neurological deficit has comprised 1.09%, and mortality 0.4%. Conclusion FD implantation is an effective and safe endovascular technique to treat cerebral aneurysms. Our experience shows that in recent years there has been a trend towards an increase in the number of implanted FDs if compared to other applied techniques without reducing the radicality and safety of endovascular treatment. The variety of currently available FDs, their technical capabilities, and improved delivery catheters make the embolization more convenient, reduce the operation time as well as the radiation and contrast loads. However, despite FD’s apparent simplicity, the need for antiplatelet therapy in the postoperative period and the restrictions on their use in the distal parts of the Willis circle and bifurcation aneurysms, not to mention their high price, still limit application of this treatment method, so further studies are required to expand the indications for the use of FDs. Disclosures K. Orlov: None. N. Strelnikov: None. V. Berestov: None. A. Somova: None. A. Brusyanskaya: None.

  • Open Access

    E-226 Endovascular treatment of pediatric arteriovenous shunts

    by V Berestov, K Orlov, N Strelnikov, A Brusyanskaya, A Somova

    Background Pediatric arteriovenous malformations (AVM) and pial/dural arteriovenous fistulas (AVF) are rare but life-threatening diseases that can lead to congestive heart failure and hemorrhagic stroke in newborns and pediatric patients. The pronounced shunting in these conditions is associated with early complications and necessitates aggressive surgical management. Materials and Methods For 10 years, our team at the Meshalkin National Medical Research Center and Federal Center of Brain Research and Neurotechnologies has accumulated extensive experience in endovascular treatment of pediatric patients with congenital cerebrovascular pathology; we have conducted a total of 158 procedures in 70 patients, including 18 endovascular interventions in 16 newborns. Overall complication rate was 14,3% (10 pts) with 10,0% (7 pts) morbidity rate. Total cure was achieved in 41 patients (58,6%). Results Based on our experience of using various embolic agents, we believe that cyanoacrylate compositions are the most suitable for AVF embolization. Due to their adhesive properties, they allow for controlled and effective occlusion of high-flow fistulas (more than 70% of procedures in our series of cases). Non-adhesive compositions are effective for final embolization of residual small feeders (28,5%).In one case (AVF formed direct communication between basilar artery and dilated deep cerebral vein) we have performed subtotal embolization of the AVF by 0,020’’ coils, which led to progressive thrombosis of the fistula with restoration of normal arterial blood flow. The patient was discharged 18 days after surgery, and MRI at 1.5 and 6 months showed the absence of blood flow through the fistula and satisfactory condition of the infant without physical and mental developmental delay. Anteroposterior (A, C) and lateral (B, D) vertebral angiograms before (A, B) and after (C, D) AVF embolization in the same phase of contrast enhancement. A significant improvement in contrast enhancement of cerebral vessels and a pronounced decrease in blood flow through the fistula are observed Conclusion Endovascular treatment of pediatric arteriovenous shunts is extremely difficult and associated with high risks of complications. However, excellent clinical results can be achieved in specialized clinics. The choice of embolic agent should depend on the hemodynamic load of the pathological blood flow. Disclosures V. Berestov: None. K. Orlov: None. N. Strelnikov: None. A. Brusyanskaya: None. A. Somova: None.